BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 34146121)

  • 1. CDK9 keeps RNA polymerase II on track.
    Egloff S
    Cell Mol Life Sci; 2021 Jul; 78(14):5543-5567. PubMed ID: 34146121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-loop phosphorylated Cdk9 localizes to nuclear speckle domains which may serve as sites of active P-TEFb function and exchange between the Brd4 and 7SK/HEXIM1 regulatory complexes.
    Dow EC; Liu H; Rice AP
    J Cell Physiol; 2010 Jul; 224(1):84-93. PubMed ID: 20201073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of the RNA polymerase II carboxyl-terminal domain by CDK9 is directly responsible for human immunodeficiency virus type 1 Tat-activated transcriptional elongation.
    Kim YK; Bourgeois CF; Isel C; Churcher MJ; Karn J
    Mol Cell Biol; 2002 Jul; 22(13):4622-37. PubMed ID: 12052871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin K functions as a CDK9 regulatory subunit and participates in RNA polymerase II transcription.
    Fu TJ; Peng J; Lee G; Price DH; Flores O
    J Biol Chem; 1999 Dec; 274(49):34527-30. PubMed ID: 10574912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional activity of positive transcription elongation factor b kinase in vivo requires the C-terminal domain of RNA polymerase II.
    Napolitano G; Majello B; Licciardo P; Giordano A; Lania L
    Gene; 2000 Aug; 254(1-2):139-45. PubMed ID: 10974544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A positive feedback loop links opposing functions of P-TEFb/Cdk9 and histone H2B ubiquitylation to regulate transcript elongation in fission yeast.
    Sansó M; Lee KM; Viladevall L; Jacques PÉ; Pagé V; Nagy S; Racine A; St Amour CV; Zhang C; Shokat KM; Schwer B; Robert F; Fisher RP; Tanny JC
    PLoS Genet; 2012; 8(8):e1002822. PubMed ID: 22876190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P-TEFb: The master regulator of transcription elongation.
    Fujinaga K; Huang F; Peterlin BM
    Mol Cell; 2023 Feb; 83(3):393-403. PubMed ID: 36599353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA polymerase II-associated factor 1 regulates the release and phosphorylation of paused RNA polymerase II.
    Yu M; Yang W; Ni T; Tang Z; Nakadai T; Zhu J; Roeder RG
    Science; 2015 Dec; 350(6266):1383-6. PubMed ID: 26659056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional elongation control of hypoxic response.
    Soliman SHA; Iwanaszko M; Zheng B; Gold S; Howard BC; Das M; Chakrabarty RP; Chandel NS; Shilatifard A
    Proc Natl Acad Sci U S A; 2024 Apr; 121(15):e2321502121. PubMed ID: 38564636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The emerging picture of CDK9/P-TEFb: more than 20 years of advances since PITALRE.
    Paparidis NF; Durvale MC; Canduri F
    Mol Biosyst; 2017 Jan; 13(2):246-276. PubMed ID: 27833949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin-dependent kinase 9 (Cdk9) of fission yeast is activated by the CDK-activating kinase Csk1, overlaps functionally with the TFIIH-associated kinase Mcs6, and associates with the mRNA cap methyltransferase Pcm1 in vivo.
    Pei Y; Du H; Singer J; Stamour C; Granitto S; Shuman S; Fisher RP
    Mol Cell Biol; 2006 Feb; 26(3):777-88. PubMed ID: 16428435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes.
    Nguyen VT; Kiss T; Michels AA; Bensaude O
    Nature; 2001 Nov; 414(6861):322-5. PubMed ID: 11713533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TFIIH and P-TEFb coordinate transcription with capping enzyme recruitment at specific genes in fission yeast.
    Viladevall L; St Amour CV; Rosebrock A; Schneider S; Zhang C; Allen JJ; Shokat KM; Schwer B; Leatherwood JK; Fisher RP
    Mol Cell; 2009 Mar; 33(6):738-51. PubMed ID: 19328067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA polymerase II transcription elongation and Pol II CTD Ser2 phosphorylation: A tail of two kinases.
    Bowman EA; Kelly WG
    Nucleus; 2014; 5(3):224-36. PubMed ID: 24879308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms controlling CDK9 activity.
    Marshall RM; Grana X
    Front Biosci; 2006 Sep; 11():2598-613. PubMed ID: 16720337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct Cdk9-phosphatase switches act at the beginning and end of elongation by RNA polymerase II.
    Parua PK; Kalan S; Benjamin B; Sansó M; Fisher RP
    Nat Commun; 2020 Aug; 11(1):4338. PubMed ID: 32859893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDK9-dependent RNA polymerase II pausing controls transcription initiation.
    Gressel S; Schwalb B; Decker TM; Qin W; Leonhardt H; Eick D; Cramer P
    Elife; 2017 Oct; 6():. PubMed ID: 28994650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase-separation mechanism for C-terminal hyperphosphorylation of RNA polymerase II.
    Lu H; Yu D; Hansen AS; Ganguly S; Liu R; Heckert A; Darzacq X; Zhou Q
    Nature; 2018 Jun; 558(7709):318-323. PubMed ID: 29849146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G-actin participates in RNA polymerase II-dependent transcription elongation by recruiting positive transcription elongation factor b (P-TEFb).
    Qi T; Tang W; Wang L; Zhai L; Guo L; Zeng X
    J Biol Chem; 2011 Apr; 286(17):15171-81. PubMed ID: 21378166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of RNA polymerase II activity by dedicated CTD kinases and phosphatases.
    Majello B; Napolitano G
    Front Biosci; 2001 Oct; 6():D1358-68. PubMed ID: 11578967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.